Konferenser och symposier The KI-J&J Innovative Medicine Partnership Annual Meeting

Background 

Collaboration between KI and J&J Innovative Medicine: Multi-faceted Research Collaboration for Advanced Real-World Evidence, Biomarker, and Translational Research. 

J&J Innovative Medicine and KI are working together with the goal of improving health outcomes for patients by accelerating and enhancing translational research and real-world evidence. The partnership is built on dynamic collaboration, openness and transparency for the mutual benefit of both organizations, advancement of science and patient outcomes.

The research collaboration in advanced real-world evidence (RWE), biomarker, and translational research was initiated by J&J Innovative Medicine (formerly Janssen Pharmaceutica NV) and Karolinska Institutet in 2015, with an initial focus on applied data science and RWE research together with pharmacoepidemiologic and RWE methods development. In 2019, this research collaboration was expanded in scope to encompass translational research, and research projects have also been initiated across additional disease areas and indications.  

Learn more about the KI- J&J Innovative Medicine partnership here

Target Group 

KI researchers, KI PhD students, KI employees, Karolinska Universitetssjukhuset (K) employees and J&J Innovative Medicine employees

Agenda 

The event will run over two consecutive half-days (afternoons) in a hybrid format and will showcase the value of the joint research program between J&J Innovative Medicine and Karolinska Institutet.

Please see the preliminary Agenda below 

Day 1, April 21^st

Hybrid with Speakers online and IRL in Nils Ringertz, room, Biomedicum, Campus Solna, KI

14:00 - 14:05 - Welcome by Partnership Operational Team (KI)

14:05- 14:30 - KI–J&J Partnership Highlights and Strategic Outlook​ by Shane Kavanagh (J&J), Mario Klesse (J&J) and Richard Cowburn (KI)

14:30- 14:40 - KI Leadership Perspective: Life Science Strategy and Partnerships by Clara Hellner, Presidential Advisor in Life Science (KI)

14:40-15:30 - Neuro‑Psychiatry: New Insights and Challenges in Schizophrenia and Bipolar Disorder by Carl Sellgren (KI), Johan Reutfors (KI), Jack Sheehan (J&J) and Ameya Kulkarni (J&J). Moderation by Paul Ashley (J&J).

15:30- 16:00 - Networking Break (coffee served)

16:00- 16:50 - Respiratory Diseases: Asthma and COPD in Focus by Mawuli Nyaku (J&J), Erik Melén (KI), William Cook (J&J)

16:50- 17:00 - Day 1 Key Takeaways and Closing Remarks by Richard Cowburn (KI)

Day 2, April 22^nd

Hybrid with Speakers online and IRL in Nils Ringertz room, Biomedicum, Campus Solna, KI

Session I - Advancing Clinical Trials

14:00- 14:30 - Clinical Trial Landscape in the Nordics: Current J&J Portfolio and Collaboration Pathways​ by Eva Adås (J&J)

14:30-15:00 - Clinical Trials: Academic and Hospital Perspectives by Stefan Mielke (KI) and Kristina Sonnevi (KI)​

15:00-15:30 Panel Discussion: Challenges and Opportunities in Clinical Trials in Sweden.

                    - Panelists: Eva Adås (J&J), Stefan Mielke (KI) and Kristina Sonnevi (KI)

                    - Panel Chair: Liv Eidsmo (KI)

15.30-16.00 Networking Break (coffee served)

Session II - Partnering with Pharma

16.00-16.30 When, Why and How to Collaborate by Paul Ashley (J&J) and KI Alliance Managers (KI)

16:30-17.00 Open Dialogue with J&J: Exploring Ideas and Opportunities by KI-J&J Partnerships' Joint Steering Committee and Operational Team (KI and J&J)

Organizers 

Karolinska Institutet in collaboration with J&J Innovative Medicine

Registration

Please use your official email address (KI, K or J&J) when signing up to this event. Information on how to join the event will be provided upon registration or upon registration closing date. 

Sign-up here, registration open until April 21^st

Contact 

Please contact alliancemanagers@ki.se if you have any questions regarding this event.